Vinson & Elkins Partners Benjamin Heriaud (left) and East Berhane (right) East Berhane and Ben Heriaud Bring Valuable Experience Working with Private Equity Sponsors and Public Companies   By Exec Edge Editorial Staff Vinson & Elkins today announced it has...

By Daniella Parra Agilent Technologies, Inc. (NYSE: A) has appointed Bret DiMarco as senior vice president and chief legal officer, also serving as secretary, the company announced Monday. DiMarco, previously the chief legal officer at Pendo.io, has extensive legal and...

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with GameSquare Holdings, Inc. (Nasdaq: GAME) to discuss the booming esports industry, the impact of the merger with FaZe as the biggest gaming worldwide brand, and more. The event...

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with GameSquare Holdings, Inc. (Nasdaq: GAME) to discuss the booming esports industry, the impact of the merger with FaZe as the biggest gaming worldwide brand, and more. The event...

By Daniella Parra Sparrow Pharmaceuticals shared data on the combination of clofutriben (SPI-62), an HSD-1 inhibitor, and prednisolone for treating polymyalgia rheumatica (PMR). The company said that HSD-1 inhibition can reduce glucocorticoid side effects while maintaining treatment efficacy and combining...

By Equities First China is leading the world in clean energy investment. In 2022, China invested $546 billion in renewable energy sources like solar and wind, electric vehicles, and battery technologies. That accounted for nearly half of the entire world’s...

By Daniella Parra NANO-X IMAGING LTD (Nasdaq: NNOX) has integrated FDA-cleared AI solutions into its Second Opinions online consultation service, offered by its subsidiary, USARAD Holdings INC, the company said. This platform connects patients with specialists for additional diagnostic consultations,...

By Daniella Parra Lisata Therapeutics (Nasdaq: LSTA), said it has fully enrolled the pancreatic cancer cohort for the CENDIFOX trial. The company said it evaluates certepetide with FOLFIRINOX therapies in pancreatic, colon, and appendiceal cancers and the trial is being...

By Karen Roman Aktis Oncology said it appointed Dr. Ken Herrmann to the Board of Directors. Dr. Herrmann specializes in nuclear medicine and has over a decade of experience in clinical investigation, the company said. “Ken’s joining us on the...

By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said the FDA allowed the beginning of a phase 1 for the clinical trial of NPM-119, its long-term mini-implant for type-2 diabetes treatment. Vivani is also advancing in the development of NPM-115...